92 related articles for article (PubMed ID: 17233821)
1. Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease.
Arcaini L; Paulli M; Burcheri S; Rossi A; Spina M; Passamonti F; Lucioni M; Motta T; Canzonieri V; Montanari M; Bonoldi E; Gallamini A; Uziel L; Crugnola M; Ramponi A; Montanari F; Pascutto C; Morra E; Lazzarino M;
Br J Haematol; 2007 Jan; 136(2):301-4. PubMed ID: 17233821
[TBL] [Abstract][Full Text] [Related]
2. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
3. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
[TBL] [Abstract][Full Text] [Related]
4. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
Oki Y; Yamamoto K; Kato H; Kuwatsuka Y; Taji H; Kagami Y; Morishima Y
Eur J Haematol; 2008 Dec; 81(6):448-53. PubMed ID: 18691256
[TBL] [Abstract][Full Text] [Related]
5. Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study.
Oh SY; Kwon HC; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Bang SM; Kim JH; Park J; Ryoo BY; Lee SS; Kim HY; Park K; Kim HJ
Cancer Lett; 2007 Dec; 258(1):90-7. PubMed ID: 17936499
[TBL] [Abstract][Full Text] [Related]
6. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma.
Marcus R; Imrie K; Solal-Celigny P; Catalano JV; Dmoszynska A; Raposo JC; Offner FC; Gomez-Codina J; Belch A; Cunningham D; Wassner-Fritsch E; Stein G
J Clin Oncol; 2008 Oct; 26(28):4579-86. PubMed ID: 18662969
[TBL] [Abstract][Full Text] [Related]
7. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in primary gastric lymphoma.
Medina-Franco H; Germes SS; Maldonado CL
Ann Surg Oncol; 2007 Aug; 14(8):2239-45. PubMed ID: 17546474
[TBL] [Abstract][Full Text] [Related]
9. Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma.
Oh SY; Ryoo BY; Kim WS; Kim K; Lee J; Kim HJ; Kwon JM; Lee HR; Ko YH; Oh SJ; Park KW; Kim HJ; Kwon HC; Nam E; Kim JH; Park YH; Lee SS; Kim HY; Park K
Ann Hematol; 2006 Nov; 85(11):781-6. PubMed ID: 16847665
[TBL] [Abstract][Full Text] [Related]
10. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
11. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
Arcaini L; Burcheri S; Rossi A; Passamonti F; Paulli M; Boveri E; Brusamolino E; Orlandi E; Molteni A; Pulsoni A; Cox MC; Orsucci L; Fabbri A; Frezzato M; Voso MT; Zaja F; Montanari F; Pascutto C; Morra E; Cortelazzo S; Lazzarino M
Oncologist; 2006 Mar; 11(3):285-91. PubMed ID: 16549813
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and treatment results of pediatric B-cell non-Hodgkin lymphoma patients in a single center.
Karadeniz C; Oguz A; Citak EC; Uluoglu O; Okur V; Demirci S; Okur A; Aksakal N
Pediatr Hematol Oncol; 2007 Sep; 24(6):417-30. PubMed ID: 17710659
[TBL] [Abstract][Full Text] [Related]
13. Primary gastric lymphoma of T-cell origin: clinicopathologic features and treatment outcome.
Park YH; Kim WS; Bang SM; Lee SI; Kang HJ; Na II; Yang SH; Lee SS; Uhm JE; Kwon JM; Kim K; Jung CW; Park K; Ko YH; Ryoo BY
Leuk Res; 2006 Oct; 30(10):1253-8. PubMed ID: 16529813
[TBL] [Abstract][Full Text] [Related]
14. Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades.
Koumarianou AA; Xiros N; Papageorgiou E; Pectasides D; Economopoulos T
Anticancer Res; 2007; 27(2):1191-7. PubMed ID: 17465262
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M
Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma.
Troch M; Wöhrer S; Raderer M
Anticancer Res; 2010 Feb; 30(2):635-9. PubMed ID: 20332482
[TBL] [Abstract][Full Text] [Related]
17. Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population.
Yang S; Yu Y; Jun-Min L; Jian-Qing M; Qiu-Sheng C; Yu C; Wei-Li Z; Jian-Hua Y; Hui-Jin Z; Yan W; Li W; Shu C; Zhi-Xiang S
Ann Hematol; 2009 Sep; 88(9):863-9. PubMed ID: 19205655
[TBL] [Abstract][Full Text] [Related]
18. Primary cardiac lymphoma: clinical, histologic, immunophenotypic, and genotypic features of 5 cases of a rare disorder.
Nascimento AF; Winters GL; Pinkus GS
Am J Surg Pathol; 2007 Sep; 31(9):1344-50. PubMed ID: 17721189
[TBL] [Abstract][Full Text] [Related]
19. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients.
Li JM; Wang L; Shen Y; Xia ZG; Chen Y; Chen QS; Chen Y; Zeng XY; You JH; Qian Y; Shen ZX
Ann Hematol; 2007 Sep; 86(9):639-45. PubMed ID: 17572895
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic analysis of 62 cases of nasal NK/T-cell lymphoma].
Xiao J; Wang SS; Huang Y; Chen LK; Guan ZZ; Huang HQ; Xia ZJ; Xu RH; Lin TY
Ai Zheng; 2006 Sep; 25(9):1173-7. PubMed ID: 16965665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
